BDBM4642 Anilinoquinazoline deriv. 25::N-(4-chloro-2-fluorophenyl)-6-methoxy-7-(thiophen-3-ylmethoxy)quinazolin-4-amine

SMILES: COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCc1ccsc1

InChI Key: InChIKey=ORADRWKXLYIOGS-UHFFFAOYSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 4642   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Vascular endothelial growth factor receptor 1 (Homo sapiens (Human))	BDBM4642 (Anilinoquinazoline deriv. 25 | N-(4-chloro-2-fluor...) Show SMILES COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCc1ccsc1 Show InChI InChI=1S/C20H15ClFN3O2S/c1-26-18-7-14-17(8-19(18)27-9-12-4-5-28-10-12)23-11-24-20(14)25-16-3-2-13(21)6-15(16)22/h2-8,10-11H,9H2,1H3,(H,23,24,25)	PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	800	n/a	n/a	n/a	n/a	n/a	25
AstraZeneca					Assay Description An ELISA assay was used to determine the ability of inhibitor to inhibit VEGF-R RTK activity. The compounds were incubated with enzyme 20 min at room...				J Med Chem 42: 5369-89 (1999) Article DOI: 10.1021/jm990345w BindingDB Entry DOI: 10.7270/Q2F47MBM
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 1 (Homo sapiens (Human))	BDBM4642 (Anilinoquinazoline deriv. 25 | N-(4-chloro-2-fluor...) Show SMILES COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCc1ccsc1 Show InChI InChI=1S/C20H15ClFN3O2S/c1-26-18-7-14-17(8-19(18)27-9-12-4-5-28-10-12)23-11-24-20(14)25-16-3-2-13(21)6-15(16)22/h2-8,10-11H,9H2,1H3,(H,23,24,25)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	>5.00E+4	n/a	n/a	n/a	n/a	n/a	25
AstraZeneca					Assay Description An ELISA assay was used to determine the ability of inhibitor to inhibit FGFR-1 TK activity. The compounds were incubated with enzyme 20 min at room ...				J Med Chem 42: 5369-89 (1999) Article DOI: 10.1021/jm990345w BindingDB Entry DOI: 10.7270/Q2F47MBM
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human))	BDBM4642 (Anilinoquinazoline deriv. 25 | N-(4-chloro-2-fluor...) Show SMILES COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCc1ccsc1 Show InChI InChI=1S/C20H15ClFN3O2S/c1-26-18-7-14-17(8-19(18)27-9-12-4-5-28-10-12)23-11-24-20(14)25-16-3-2-13(21)6-15(16)22/h2-8,10-11H,9H2,1H3,(H,23,24,25)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	25
AstraZeneca					Assay Description An ELISA assay was used to determine the ability of inhibitor to inhibit VEGF-R RTK activity. The compounds were incubated with enzyme 20 min at room...				J Med Chem 42: 5369-89 (1999) Article DOI: 10.1021/jm990345w BindingDB Entry DOI: 10.7270/Q2F47MBM
					More data for this Ligand-Target Pair